FFT Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,541
Closed -$203K 157
2024
Q4
$203K Sell
2,541
-79
-3% -$6.84K 0.02% 180
2024
Q3
$236K Buy
+2,620
New +$220K 0.02% 156
2024
Q2
Sell
-2,351
Closed -$205K 162
2024
Q1
$205K Buy
+2,351
New +$201K 0.02% 149
2021
Q4
Sell
-1,952
Closed -$245K 84
2021
Q3
$245K Buy
1,952
+230
+13% +$29.8K 0.02% 77
2021
Q2
$214K Buy
+1,722
New +$216K 0.05% 61

Other funds holding MDT

FFT Wealth Management's MDT Position: Q1 2025 in Review

FFT Wealth Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 2,541 shares — an estimated $203K sold.

FFT Wealth Management first reported a position in MDT in Q2 2021 and held it in 5 quarters. The position peaked at $245K in Q3 2021. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • FFT Wealth Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • FFT Wealth Management sold 2,541 Medtronic shares in Q1 2025, an estimated $203K.
  • FFT Wealth Management first reported a position in Medtronic in Q2 2021 and held it in 5 quarters.
  • FFT Wealth Management's Medtronic position peaked at $245K in Q3 2021.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on FFT Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.